|
US5744500A
(en)
*
|
1990-01-03 |
1998-04-28 |
Teva Pharmaceutical Industries, Ltd. |
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
|
|
IL118836A
(en)
*
|
1996-07-11 |
2001-01-11 |
Teva Pharma |
Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan
|
|
EP1242066B1
(en)
|
1999-10-27 |
2006-06-28 |
Teva Pharmaceutical Industries Ltd. |
Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder
|
|
EP2526944B1
(en)
*
|
2002-11-15 |
2016-06-01 |
Teva Pharmaceutical Industries Limited |
Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis
|
|
GB2411355B
(en)
|
2004-02-27 |
2006-02-22 |
Niche Generics Ltd |
Pharmaceutical composition
|
|
EP1778196A4
(en)
*
|
2004-07-26 |
2008-12-17 |
Teva Pharma |
PHARMACEUTICAL DOSAGES CONTAINING RASAGILINE
|
|
EP1729735B1
(en)
*
|
2004-11-10 |
2007-06-27 |
Teva Pharmaceutical Industries Ltd. |
Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
|
|
US8367105B2
(en)
|
2004-11-10 |
2013-02-05 |
Teva Pharmaceutical Industries, Ltd. |
Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
|
|
ATE521343T1
(de)
*
|
2004-11-24 |
2011-09-15 |
Teva Pharma |
Im mund zerfallende zusammensetzungen von rasagilin
|
|
US20100167983A1
(en)
*
|
2007-10-22 |
2010-07-01 |
Teva Pharmaceutical Industries, Ltd. |
Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
|
|
CA2596664A1
(en)
*
|
2005-02-17 |
2006-08-24 |
Teva Pharmaceutical Industries Ltd. |
Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
|
|
KR20140103356A
(ko)
*
|
2005-02-23 |
2014-08-26 |
테바 파마슈티컬 인더스트리즈 리미티드 |
함량 균일성이 개선된 라사길린 제형
|
|
EP1954667B1
(en)
*
|
2005-11-17 |
2017-02-08 |
Teva Pharmaceutical Industries Ltd |
Methods for isolating propargylated aminoindans
|
|
US7572834B1
(en)
|
2005-12-06 |
2009-08-11 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline formulations and processes for their preparation
|
|
EP1956904B1
(en)
|
2005-12-09 |
2017-04-12 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Low-dose ladostigil for the treatment of mild cognitive impairment
|
|
EP1991214B1
(en)
|
2006-02-21 |
2015-08-05 |
Teva Pharmaceutical Industries, Ltd. |
Use of rasagiline for the treatment of multiple system atrophy
|
|
TW200744576A
(en)
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|
|
EP2007369A4
(en)
|
2006-04-03 |
2009-07-01 |
Teva Pharma |
USE OF RASAGILINE FOR THE TREATMENT OF LEG SYNDROME WITHOUT REST
|
|
DE202006020710U1
(de)
|
2006-05-09 |
2009-12-31 |
Teva Pharmaceutical Industries Ltd. |
Zusammensetzungen mit Rosiglitazonmaleat
|
|
EP1892233A1
(de)
*
|
2006-08-18 |
2008-02-27 |
Ratiopharm GmbH |
Neue Salze des Wirkstoffs Rasagilin
|
|
WO2008076315A1
(en)
*
|
2006-12-14 |
2008-06-26 |
Teva Pharmaceutical Industries, Ltd. |
Tannate salt of rasagiline
|
|
EA016820B1
(ru)
*
|
2006-12-14 |
2012-07-30 |
Тева Фармасьютикал Индастриз, Лтд. |
Кристаллическое твердое основание разагилина
|
|
EP1987816A1
(de)
*
|
2007-04-30 |
2008-11-05 |
Ratiopharm GmbH |
Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff
|
|
EP2194780A4
(en)
*
|
2007-09-05 |
2010-10-27 |
Teva Pharma |
METHOD FOR TREATING GLAUCOMA BY RASAGILINE
|
|
US8188149B2
(en)
*
|
2007-09-17 |
2012-05-29 |
Teva Pharmaceutical Industries, Ltd. |
Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
|
|
NZ586025A
(en)
*
|
2008-01-11 |
2012-08-31 |
Teva Pharma |
Rasagiline mesylate tablet coated with a composisiton comprising methacrylic acid - ethyl acrylate copolymer and triethyl citrate
|
|
US20090247537A1
(en)
*
|
2008-03-25 |
2009-10-01 |
William Dale Overfield |
Methods for preventing or treating bruxism using dopaminergic agents
|
|
US20110117200A1
(en)
*
|
2008-03-31 |
2011-05-19 |
Actavis Group Ptc Ehf |
Rasagiline mesylate particles and process for the preparation thereof
|
|
JP2011522892A
(ja)
*
|
2008-06-13 |
2011-08-04 |
テバ ファーマシューティカル インダストリーズ リミティド |
パーキンソン病緩和のためのラサギリン
|
|
CA2727021A1
(en)
*
|
2008-06-19 |
2009-12-23 |
Teva Pharmaceutical Industries Ltd. |
Process for purifying rasagiline base
|
|
WO2009154777A2
(en)
|
2008-06-19 |
2009-12-23 |
Teva Pharmaceutical Industries, Ltd. |
Process for preparing and drying solid rasagiline base
|
|
US8080584B2
(en)
*
|
2009-01-23 |
2011-12-20 |
Teva Pharmaceuticals Industries, Ltd. |
Delayed release rasagiline citrate formulation
|
|
EP2218444A3
(en)
|
2009-01-23 |
2010-08-25 |
Teva Pharmaceutical Industries, Ltd. |
Delayed release rasagiline formulation
|
|
CA2754089A1
(en)
|
2009-03-05 |
2010-09-10 |
Sandoz Ag |
Pharmaceutical composition containing 1h-inden-1-amine, 2,3-dihydro-n-2-propynyl-, (1r)-, methanesulfonate
|
|
RS53504B1
(sr)
|
2009-07-09 |
2015-02-27 |
Ratiopharm Gmbh |
Soli razagilina i njihovi farmaceutski preparati
|
|
CN102048717B
(zh)
†
|
2009-10-29 |
2014-02-19 |
重庆医药工业研究院有限责任公司 |
一种稳定的雷沙吉兰组合物
|
|
EP2939669A1
(en)
|
2009-12-22 |
2015-11-04 |
Teva Pharmaceutical Industries, Ltd. |
3-keto-n-propargyl-1-aminoindan
|
|
WO2011139420A2
(en)
|
2010-04-30 |
2011-11-10 |
Teikoku Pharma Usa, Inc. |
Propynylaminoindan transdermal compositions
|
|
EP2389927A1
(en)
|
2010-05-30 |
2011-11-30 |
Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi |
Pharmaceutical formulations of rasagiline
|
|
AU2011282716A1
(en)
|
2010-07-27 |
2013-03-14 |
Teva Pharmaceutical Industries Ltd. |
Dispersions of rasagiline citrate
|
|
AU2011282720B2
(en)
|
2010-07-27 |
2016-12-22 |
Teva Pharmaceutical Industries Ltd. |
Use of rasagiline for the treatment of olfactory dysfunction
|
|
KR101853082B1
(ko)
|
2011-03-24 |
2018-04-27 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
활성제층 및 활성제 변환층을 포함하는 경피 조성물
|
|
AU2012323351A1
(en)
|
2011-10-10 |
2014-05-22 |
Teva Pharmaceutical Industries Ltd. |
R(+)-N-methyl-propargyl-aminoindan
|
|
KR20140090996A
(ko)
*
|
2011-10-10 |
2014-07-18 |
테바 파마슈티컬 인더스트리즈 리미티드 |
R(+)-n-폼일-프로파길-아미노인단
|
|
US20130089611A1
(en)
*
|
2011-10-10 |
2013-04-11 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline citramide
|
|
EP2776020B1
(en)
|
2011-11-09 |
2019-09-11 |
Teikoku Seiyaku Co., Ltd. |
Methods for the treatment of skin neoplasms
|
|
DE102012000786A1
(de)
|
2012-01-18 |
2013-07-18 |
Stada Arzneimittel Ag |
Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung, enthaltend den Wirkstoff Rasagilin
|
|
EP2827848B1
(en)
|
2012-03-21 |
2016-04-27 |
Synthon BV |
Stabilized pharmaceutical compositions comprising rasagiline salts
|
|
WO2013175493A1
(en)
|
2012-04-09 |
2013-11-28 |
Cadila Healthcare Limited |
Stable oral pharmaceutical compositions
|
|
JP2015529196A
(ja)
|
2012-08-17 |
2015-10-05 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラサギリンの非経口製剤
|
|
KR20150059177A
(ko)
|
2012-11-02 |
2015-05-29 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
프로피닐아미노인단 경피 조성물
|
|
EP2764862A1
(en)
*
|
2013-02-06 |
2014-08-13 |
Galenicum Health S.L. |
Immediate release tablets of rasagiline hemitartrate
|
|
ES2524865T1
(es)
*
|
2013-02-06 |
2014-12-15 |
Galenicum Health S.L. |
Composiciones farmacéuticas estables en forma de comprimidos de liberación inmediata
|
|
CN115400090A
(zh)
*
|
2022-10-09 |
2022-11-29 |
北京新领先医药科技发展有限公司 |
一种雷沙吉兰的口崩片组合物及其制备方法
|